SCHEMBL24752422

SCHEMBL24752422

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5ccc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)cc5)c5ccccc45)nc(-c4ccc(-c5ccccc5)cc4)n3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ATM Q13315 1/20 0.43
▸ MEN1 O00255 6/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ HPGD P15428 6/20 0.40
▸ MAPT P10636 6/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ NTSR1 P30989 1/20 0.40
▸ PTGER4 P35408 1/20 0.38
▸ LMNA P02545 2/20 0.36
▸ GLA P06280 1/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ TSPO P30536 1/20 0.35
▸ CYP2C19 P33261 2/20 0.34
▸ ACACA Q13085 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24753861 1.00 KDM4E (0.43) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24752562 1.00 KDM4E (0.43) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24752059 1.00 KDM4E (0.43) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24752518 1.00 KDM4E (0.43) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24787753 0.98 KMT2A (0.40) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24752184 0.98 KMT2A (0.40) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24752421 0.98 MEN1 (0.42) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL26431975 0.96 KDM4E (0.44) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24752513 0.95 KDM4E (0.41) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL26432138 0.95 MEN1 (0.39) KDM4EL3MBTL1ATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
EP-4101851-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2022-12-14 — — EP disclosed
EP-4101847-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2022-12-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, EPCAM, TMEM109 KDM4E 3098/4885L3MBTL1 1434/4885ATM 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback